BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 19413886)

  • 1. URG11 promotes gastric cancer growth and invasion by activation of beta-catenin signalling pathway.
    Du R; Xia L; Sun S; Lian Z; Zou X; Gao J; Xie H; Fan R; Song J; Li X; Liu J; Fan D
    J Cell Mol Med; 2010 Mar; 14(3):621-35. PubMed ID: 19413886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced cell survival of Hep3B cells by the hepatitis B x antigen effector, URG11, is associated with upregulation of beta-catenin.
    Lian Z; Liu J; Li L; Li X; Clayton M; Wu MC; Wang HY; Arbuthnot P; Kew M; Fan D; Feitelson MA
    Hepatology; 2006 Mar; 43(3):415-24. PubMed ID: 16496348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knockdown of Upregulated Gene 11 (URG11) Inhibits Proliferation, Invasion, and β-Catenin Expression in Non-Small Cell Lung Cancer Cells.
    Liu ZL; Wu J; Wang LX; Yang JF; Xiao GM; Sun HP; Chen YJ
    Oncol Res; 2016; 24(3):197-204. PubMed ID: 27458101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. URG11 mediates hypoxia-induced epithelial-to-mesenchymal transition by modulation of E-cadherin and beta-catenin.
    Du R; Huang C; Bi Q; Zhai Y; Xia L; Liu J; Sun S; Fan D
    Biochem Biophys Res Commun; 2010 Jan; 391(1):135-41. PubMed ID: 19900406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. URG11 Regulates Prostate Cancer Cell Proliferation, Migration, and Invasion.
    Pan B; Ye Y; Liu H; Zhen J; Zhou H; Li Y; Qu L; Wu Y; Zeng C; Zhong W
    Biomed Res Int; 2018; 2018():4060728. PubMed ID: 29955600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. URG11 promotes proliferation and induced apoptosis of LNCaP cells.
    Sun C; Zhang G; Cheng S; Qian H; Li D; Liu M
    Int J Mol Med; 2019 May; 43(5):2075-2085. PubMed ID: 30864678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Egr-1 promotes cell proliferation and invasion by increasing β-catenin expression in gastric cancer.
    Sun T; Tian H; Feng YG; Zhu YQ; Zhang WQ
    Dig Dis Sci; 2013 Feb; 58(2):423-30. PubMed ID: 22918686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Silencing of WISP3 suppresses gastric cancer cell proliferation and metastasis and inhibits Wnt/β-catenin signaling.
    Fang F; Zhao WY; Li RK; Yang XM; Li J; Ao JP; Jiang SH; Kong FZ; Tu L; Zhuang C; Qin WX; He P; Zhang WM; Cao H; Zhang ZG
    Int J Clin Exp Pathol; 2014; 7(10):6447-61. PubMed ID: 25400723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-1225-5p inhibits proliferation and metastasis of gastric carcinoma through repressing insulin receptor substrate-1 and activation of β-catenin signaling.
    Zheng H; Zhang F; Lin X; Huang C; Zhang Y; Li Y; Lin J; Chen W; Lin X
    Oncotarget; 2016 Jan; 7(4):4647-63. PubMed ID: 26684358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Krüppel-like factor 4 negatively regulates β-catenin expression and inhibits the proliferation, invasion and metastasis of gastric cancer.
    Zhang N; Zhang J; Shuai L; Zha L; He M; Huang Z; Wang Z
    Int J Oncol; 2012 Jun; 40(6):2038-48. PubMed ID: 22407433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HOXB5 induces invasion and migration through direct transcriptional up-regulation of β-catenin in human gastric carcinoma.
    Hong CS; Jeong O; Piao Z; Guo C; Jung MR; Choi C; Park YK
    Biochem J; 2015 Dec; 472(3):393-403. PubMed ID: 26467157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. beta-Catenin/Wnt signaling regulates expression of the membrane type 3 matrix metalloproteinase in gastric cancer.
    Lowy AM; Clements WM; Bishop J; Kong L; Bonney T; Sisco K; Aronow B; Fenoglio-Preiser C; Groden J
    Cancer Res; 2006 May; 66(9):4734-41. PubMed ID: 16651426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short hairpin RNA targeting beta-catenin suppresses cell proliferation and induces apoptosis in human gastric carcinoma cells.
    Jiang H; Xia J; Kang J; Ding Y; Wu W
    Scand J Gastroenterol; 2009; 44(12):1452-62. PubMed ID: 19958059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CDK5RAP3 acts as a tumor suppressor in gastric cancer through inhibition of β-catenin signaling.
    Wang JB; Wang ZW; Li Y; Huang CQ; Zheng CH; Li P; Xie JW; Lin JX; Lu J; Chen QY; Cao LL; Lin M; Tu RH; Lin Y; Huang CM
    Cancer Lett; 2017 Jan; 385():188-197. PubMed ID: 27793695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knockdown of DDX46 suppresses the proliferation and invasion of gastric cancer through inactivating Akt/GSK-3β/β-catenin pathway.
    Chen L; Xu M; Zhong W; Hu Y; Wang G
    Exp Cell Res; 2021 Feb; 399(1):112448. PubMed ID: 33347858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of FOXS1 in gastric cancer cell lines inhibits proliferation, metastasis, and epithelial-mesenchymal transition of tumor through downregulating wnt/β-catenin pathway.
    Lu Q; Ma X; Li Y; Song W; Zhang L; Shu Y; Wan B
    J Cell Biochem; 2019 Mar; 120(3):2897-2907. PubMed ID: 30500980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Up-regulation of human cervical cancer proto-oncogene contributes to hepatitis B virus-induced malignant transformation of hepatocyte by down-regulating E-cadherin.
    Li J; Dai X; Zhang H; Zhang W; Sun S; Gao T; Kou Z; Yu H; Guo Y; Du L; Jiang S; Zhang J; Zhou Y
    Oncotarget; 2015 Oct; 6(30):29196-208. PubMed ID: 26470691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RACK1 suppresses gastric tumorigenesis by stabilizing the β-catenin destruction complex.
    Deng YZ; Yao F; Li JJ; Mao ZF; Hu PT; Long LY; Li G; Ji XD; Shi S; Guan DX; Feng YY; Cui L; Li DS; Liu Y; Du X; Guo MZ; Xu LY; Li EM; Wang HY; Xie D
    Gastroenterology; 2012 Apr; 142(4):812-823.e15. PubMed ID: 22240482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastrin promotes the metastasis of gastric carcinoma through the β-catenin/TCF-4 pathway.
    Zhuang K; Yan Y; Zhang X; Zhang J; Zhang L; Han K
    Oncol Rep; 2016 Sep; 36(3):1369-76. PubMed ID: 27430592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of beta-catenin expression in metastatic gastric cancer.
    Ebert MP; Yu J; Hoffmann J; Rocco A; Röcken C; Kahmann S; Müller O; Korc M; Sung JJ; Malfertheiner P
    J Clin Oncol; 2003 May; 21(9):1708-14. PubMed ID: 12721245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.